Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Appointed director
CC transcript
Inv. presentation
|
|
VIROPHARMA INC (VPHM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/28/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/28/2014 |
4
| CLAYPOOL WILLIAM D MD (Director) has filed a Form 4 on VIROPHARMA INC |
| 01/28/2014 |
4
| McHugh Julie (Director) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Unknown transaction of 8,666 shares
@ $50, valued at
$433.3k
Disposed/sold 15,000 options to buy
@ $31.74, valued at
$476.1k
Disposed/sold 15,000 options to buy
@ $25.25, valued at
$378.8k
Disposed/sold 4,500 restricted stock units
@ $0
Disposed/sold 2,084 restricted stock units
@ $0
Disposed/sold 12,500 options to buy
@ $27.99, valued at
$349.9k
|
|
| 01/28/2014 |
4
| Leone John R (Director) has filed a Form 4 on VIROPHARMA INC |
| 01/28/2014 |
4
| GLASER ROBERT (Director) has filed a Form 4 on VIROPHARMA INC |
| 01/28/2014 |
4
| DOUGHERTY MICHAEL R (Director) has filed a Form 4 on VIROPHARMA INC |
| 01/28/2014 |
4
| BROOKE PAUL A (Director) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Unknown transaction of 128,314 shares
@ $50, valued at
$6.4M
Disposed/sold 15,000 options to buy
@ $10.76, valued at
$161.4k
Disposed/sold 25,000 options to buy
@ $3, valued at
$75k
Disposed/sold 10,000 options to buy
@ $9.15, valued at
$91.5k
Disposed/sold 10,000 options to buy
@ $20.15, valued at
$201.5k
Disposed/sold 10,000 options to buy
@ $17.76, valued at
$177.6k
Disposed/sold 15,000 options to buy
@ $25.25, valued at
$378.8k
Disposed/sold 15,000 options to buy
@ $31.74, valued at
$476.1k
Disposed/sold 15,000 options to buy
@ $17.3, valued at
$259.5k
Disposed/sold 15,000 options to buy
@ $5.68, valued at
$85.2k
Disposed/sold 4,500 restricted stock units
@ $0 |
|
| 01/28/2014 |
4
| Wolf John Peter III (VP, General Counsel) has filed a Form 4 on VIROPHARMA INC |
| 01/28/2014 |
4
| SOLAND DANIEL B (VP, COO) has filed a Form 4 on VIROPHARMA INC |
| 01/28/2014 |
4
| Rowland Charles A Jr (VP, CFO) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Unknown transaction of 87,026 shares
@ $50, valued at
$4.4M
Granted 48,878 shares
@ $0
Disposed/sold 48,878 shares
@ $0
Disposed/sold 52,593 options to buy
@ $13.5, valued at
$710k
Disposed/sold 13,714 options to buy
@ $8.86, valued at
$121.5k
Disposed/sold 50,000 options to buy
@ $11.31, valued at
$565.5k
Disposed/sold 40,261 options to buy
@ $17.84, valued at
$718.3k
Disposed/sold 40,261 options to buy
@ $17.98, valued at
$723.9k
Disposed/sold 27,265 options to buy
@ $28.16, valued at
$767.8k
Disposed/sold 35,723 options to buy
@ $20.07, valued at
$717k
Disposed/sold 34,570 options to buy
@ $23.37, valued at
$807.9k
|
|
| 01/28/2014 |
4
| Pietrusko Robert (VP, Regulatory & Quality) has filed a Form 4 on VIROPHARMA INC |
| 01/28/2014 |
4
| MILANO VINCENT (President and CEO) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Unknown transaction of 482,281 shares
@ $50, valued at
$24.1M
Granted 311,798 shares
@ $0
Disposed/sold 311,798 shares
@ $0
Disposed/sold 54,932 options to buy
@ $19.73, valued at
$1.1M
Disposed/sold 33,714 options to buy
@ $8.86, valued at
$298.7k
Disposed/sold 17,500 options to buy
@ $11.31, valued at
$197.9k
Disposed/sold 80,521 options to buy
@ $17.84, valued at
$1.4M
Disposed/sold 80,521 options to buy
@ $17.98, valued at
$1.4M
Disposed/sold 54,530 options to buy
@ $28.16, valued at
$1.5M
Disposed/sold 71,447 options to buy
@ $20.07, valued at
$1.4M
Disposed/sold 65,299 options to buy
@ $23.37, valued at
$1.5M
|
|
| 01/28/2014 |
4
| Kirby John J. (V.P., Chief Accounting Officer) has filed a Form 4 on VIROPHARMA INC |
| 01/28/2014 |
4
| Fletcher Robert C. (V.P., Business Development) has filed a Form 4 on VIROPHARMA INC |
| 01/28/2014 |
4
| DOYLE THOMAS F (VP Strategic Initiatives) has filed a Form 4 on VIROPHARMA INC |
| 01/28/2014 |
4
| Broom Colin MD (VP & Chief Scientific Officer) has filed a Form 4 on VIROPHARMA INC |
| 01/22/2014 |
4
| DOYLE THOMAS F (VP Strategic Initiatives) has filed a Form 4 on VIROPHARMA INC |
| 01/21/2014 |
4
| Wolf John Peter III (VP, General Counsel) has filed a Form 4 on VIROPHARMA INC |
| 01/21/2014 |
4
| MILANO VINCENT (President and CEO) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Exercised 18,582 options to buy
@ $3.14, valued at
$58.3k
Exercised 7,503 options to buy
@ $7.05, valued at
$52.9k
Exercised 5,068 options to buy
@ $19.73, valued at
$100k
Exercised 6,561 options to buy
@ $15.24, valued at
$100k
Exercised 6,251 options to buy
@ $9.96, valued at
$62.3k
Exercised 3,778 options to buy
@ $9.99, valued at
$37.7k
Exercised 7,407 options to buy
@ $13.5, valued at
$100k
Exercised 12,690 options to buy
@ $5.91, valued at
$75k
Exercised 11,286 options to buy
@ $8.86, valued at
$100k
|
|
| 01/10/2014 |
4
| SOLAND DANIEL B (VP, COO) has filed a Form 4 on VIROPHARMA INC |
| 01/10/2014 |
4
| Rowland Charles A Jr (VP, CFO) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Paid exercise price by delivering 847 shares
@ $49.8, valued at
$42.2k
Paid exercise price by delivering 2,773 shares
@ $49.8, valued at
$138.1k
Paid exercise price by delivering 2,271 shares
@ $49.8, valued at
$113.1k
Paid exercise price by delivering 558 shares
@ $49.8, valued at
$27.8k
Exercised 5,460 options to buy
@ $5.91, valued at
$32.3k
Exercised 13,080 options to buy
@ $8.86, valued at
$115.9k
Exercised 8,361 options to buy
@ $11.96, valued at
$100k
Exercised 1,852 options to buy
@ $13.5, valued at
$25k
|
|
| 01/10/2014 |
4
| Pietrusko Robert (VP, Regulatory & Quality) has filed a Form 4 on VIROPHARMA INC |
| 01/10/2014 |
4
| Broom Colin MD (VP & Chief Scientific Officer) has filed a Form 4 on VIROPHARMA INC |
| 01/08/2014 |
4
| BROOKE PAUL A (Director) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Paid exercise price by delivering 686 shares
@ $49.89, valued at
$34.2k
Exercised 10,000 options to buy
@ $3.42, valued at
$34.2k
|
|
| 01/07/2014 |
4
| MILANO VINCENT (President and CEO) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Exercised 40,309 options to buy
@ $3.55, valued at
$143.1k
|
|
| 01/03/2014 |
4
| McHugh Julie (Director) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Granted 2,083 shares
@ $0 |
|
| 12/31/2013 |
4
| Pietrusko Robert (VP, Regulatory & Quality) has filed a Form 4 on VIROPHARMA INC |
| 12/31/2013 |
4
| Rowland Charles A Jr (VP, CFO) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Paid exercise price by delivering 704 shares
@ $49.86, valued at
$35.1k
Exercised 4,540 options to buy
@ $5.91, valued at
$26.8k
|
|
| 12/31/2013 |
4
| SOLAND DANIEL B (VP, COO) has filed a Form 4 on VIROPHARMA INC |
| 12/20/2013 |
4
| Pietrusko Robert (VP, Regulatory & Quality) has filed a Form 4 on VIROPHARMA INC |
| 12/20/2013 |
4
| Rowland Charles A Jr (VP, CFO) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Paid exercise price by delivering 9,330 shares
@ $49.74, valued at
$464.1k
Paid exercise price by delivering 3,964 shares
@ $49.74, valued at
$197.2k
Paid exercise price by delivering 11,835 shares
@ $49.74, valued at
$588.7k
Exercised 15,800 options to buy
@ $11.96, valued at
$189k
Exercised 10,000 options to buy
@ $5.91, valued at
$59.1k
Exercised 23,206 options to buy
@ $8.86, valued at
$205.6k
|
|
| 12/20/2013 |
4
| DOUGHERTY MICHAEL R (Director) has filed a Form 4 on VIROPHARMA INC |
| 12/20/2013 |
4
| SOLAND DANIEL B (VP, COO) has filed a Form 4 on VIROPHARMA INC |
| 12/20/2013 |
4
| MILANO VINCENT (President and CEO) has filed a Form 4 on VIROPHARMA INC|
Txns:
| Paid exercise price by delivering 15,655 shares
@ $49.74, valued at
$778.7k
Paid exercise price by delivering 33,441 shares
@ $49.74, valued at
$1.7M
Paid exercise price by delivering 30,410 shares
@ $49.74, valued at
$1.5M
Paid exercise price by delivering 30,706 shares
@ $49.74, valued at
$1.5M
Paid exercise price by delivering 10,704 shares
@ $49.74, valued at
$532.4k
Paid exercise price by delivering 63,528 shares
@ $49.74, valued at
$3.2M
Paid exercise price by delivering 46,649 shares
@ $49.74, valued at
$2.3M
Paid exercise price by delivering 522 shares
@ $49.74, valued at
$26k
Paid exercise price by delivering 75,462 shares
@ $49.74, valued at
$3.8M
Paid exercise price by delivering 30,733 shares
@ $49.74, valued at
$1.5M
Exercised 32,497 options to buy
@ $7.05, valued at
$229.1k
|
|
|
|
|